Davis Polk advised the joint book-running managers and representatives of the several underwriters in the offering.IVERIC bio Inc. executed a $173.4 million SEC-registered offering of 10,350,000 shares of…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Laura Testa
…
This content is for Standard 1 Year members only. LoginJoin Now